EW News and Press, Edwards Lifesciences Corporation From 04/23/20

Edwards Lifesciences Corporation (EW) Q1 2020 Results Conference Call April 23, 2020 5:00 PM ET Company Participants Mark Wilterding - VP, IR Mike Mussallem - Chairman & CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America David Lewis - Mo...

Image source: The Motley Fool. Edwards Lifesciences Corp   (NYSE: EW) Q1 2020 Earnings Call Apr 23, 2020 , 5:00 p.m. ET Operator Continue reading

Edwards Lifesciences (NYSE: EW ) Q1 results : More news on: Edwards Lifesciences Corporation, Healthcare stocks news, Earnings news and commentary, , Read more ...

Edwards Lifesciences (NYSE: EW ): Q1 Non-GAAP EPS of $1.51 beats by $0.29 ; GAAP EPS of $1.47 beats by $0.50 . More news on: Edwards Lifesciences Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...

Edwards Lifesciences (NYSE: EW ) is scheduled to announce Q1 earnings results on Thursday, April 23rd, after market close. The consensus EPS Estimate is $1.22 (-7.6% Y/Y) and the consensus Revenue Estimate is $1.03B (+3.7% Y/Y). Over the last 2 years, EW has beaten EPS estimates 75% ...

Axovant Gene Therapies (NASDAQ: AXGT ) initiated with Overweight rating and $11 (209% upside) price target at Cantor Fitzgerald. More news on: Axovant Gene Therapies Ltd., Biohaven Pharmaceutical Holding Company Ltd., Coherus BioSciences, Inc., Healthcare stocks news, Stocks on the move, ,...

Original Post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...

IRVINE, Calif. , April 13, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that its Annual Meeting of Stockholders (Annual Meeting) will be held in...

The coronavirus outbreak has put pressure on medical device companies as hospitals postpone elective procedures to focus on the influx of patients. The effect on Abbott Laboratories (NYSE: ABT) , however, may be limited because of the types of medical devices the company sells and the diversi...

IRVINE, Calif. , April 9, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended March 31, 2020 after the ...